More To FDA AdComm Selection Process Than Meets The Eye
This article was originally published in The Gray Sheet
FDA issued a draft guidance on how it addresses "appearance issues" when it comes to reviewing conflicts of interest in prospective members of an advisory committee. The agency says the guidelines are needed due to a general lack of understanding about how FDA selects and evaluates members of its panels, and how it grants waivers to participate.
Register for our free email digests: